DNA methylation associates with clinical courses of atypical meningiomas: a matched case-control study

BackgroundAccounting for 15-20% of all meningiomas, WHO grade II meningiomas represent an intermediate group regarding risk of tumor recurrence. However, even within this subgroup varying clinical courses are observed with potential occurrence of multiple recurrences. Recently, DNA methylation profi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Millesi, Matthias (VerfasserIn) , Ryba, Alice Senta (VerfasserIn) , Hainfellner, Johannes A. (VerfasserIn) , Roetzer, Thomas (VerfasserIn) , Bergmeister-Berghoff, Anna Sophie (VerfasserIn) , Preusser, Matthias (VerfasserIn) , Heller, Gerwin (VerfasserIn) , Tomasich, Erwin (VerfasserIn) , Sahm, Felix (VerfasserIn) , Roessler, Karl (VerfasserIn) , Wolfsberger, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 09 March 2022
In: Frontiers in oncology
Year: 2022, Jahrgang: 12, Pages: 1-10
ISSN:2234-943X
DOI:10.3389/fonc.2022.811729
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3389/fonc.2022.811729
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/article/10.3389/fonc.2022.811729
Volltext
Verfasserangaben:Matthias Millesi, Alice Senta Ryba, Johannes A. Hainfellner, Thomas Roetzer, Anna Sophie Berghoff, Matthias Preusser, Gerwin Heller, Erwin Tomasich, Felix Sahm, Karl Roessler and Stefan Wolfsberger

MARC

LEADER 00000caa a2200000 c 4500
001 1801710732
003 DE-627
005 20230525084053.0
007 cr uuu---uuuuu
008 220513s2022 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2022.811729  |2 doi 
035 |a (DE-627)1801710732 
035 |a (DE-599)KXP1801710732 
035 |a (OCoLC)1341460004 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Millesi, Matthias  |e VerfasserIn  |0 (DE-588)125744591X  |0 (DE-627)1801712867  |4 aut 
245 1 0 |a DNA methylation associates with clinical courses of atypical meningiomas  |b a matched case-control study  |c Matthias Millesi, Alice Senta Ryba, Johannes A. Hainfellner, Thomas Roetzer, Anna Sophie Berghoff, Matthias Preusser, Gerwin Heller, Erwin Tomasich, Felix Sahm, Karl Roessler and Stefan Wolfsberger 
264 1 |c 09 March 2022 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.05.2022 
520 |a BackgroundAccounting for 15-20% of all meningiomas, WHO grade II meningiomas represent an intermediate group regarding risk of tumor recurrence. However, even within this subgroup varying clinical courses are observed with potential occurrence of multiple recurrences. Recently, DNA methylation profiles showed their value for distinguishing biological behaviors in meningiomas. Therefore, aim of this study was to investigate DNA methylation profiles in WHO grade II meningiomas.MethodsAll patients that underwent resection of WHO grade II meningiomas between 1993 and 2015 were screened for a dismal course clinical course with ≥2 recurrences. These were matched to control cases with benign clinical courses without tumor recurrence. DNA methylation was assessed using the Infinium Methylation EPIC BeadChip microarray. Unsupervised hierarchical clustering was performed for identification of DNA methylation profiles associated with such a dismal clinical course.ResultsOverall, 11 patients with WHO grade II meningiomas with ≥2 recurrences (Group dismal) and matched 11 patients without tumor recurrence (Group benign) were identified. DNA methylation profiles revealed 3 clusters—one comprising only patients of group dismal, a second cluster comprising mainly patients from group benign and a third cluster comprising one group dismal and one group benign patient. Based on differential methylation pattern associations with the Wnt and the related cadherin signaling pathway was observed.ConclusionDNA methylation clustering showed remarkable differences between two matched subgroups of WHO grade II meningiomas. Thus, DNA methylation profiles may have the potential to support prognostic considerations regarding meningioma recurrence and radiotherapeutic treatment allocation after surgical resection. 
700 1 |a Ryba, Alice Senta  |e VerfasserIn  |4 aut 
700 1 |a Hainfellner, Johannes A.  |e VerfasserIn  |4 aut 
700 1 |a Roetzer, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Bergmeister-Berghoff, Anna Sophie  |d 1987-  |e VerfasserIn  |0 (DE-588)1139308564  |0 (DE-627)897062426  |0 (DE-576)493233059  |4 aut 
700 1 |a Preusser, Matthias  |d 1976-  |e VerfasserIn  |0 (DE-588)1156333008  |0 (DE-627)1019103949  |0 (DE-576)502110627  |4 aut 
700 1 |a Heller, Gerwin  |e VerfasserIn  |4 aut 
700 1 |a Tomasich, Erwin  |e VerfasserIn  |4 aut 
700 1 |a Sahm, Felix  |d 1984-  |e VerfasserIn  |0 (DE-588)1022852132  |0 (DE-627)717318478  |0 (DE-576)366075020  |4 aut 
700 1 |a Roessler, Karl  |e VerfasserIn  |4 aut 
700 1 |a Wolfsberger, Stefan  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 12(2022), Artikel-ID 811729, Seite 1-10  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a DNA methylation associates with clinical courses of atypical meningiomas a matched case-control study 
773 1 8 |g volume:12  |g year:2022  |g elocationid:811729  |g pages:1-10  |g extent:10  |a DNA methylation associates with clinical courses of atypical meningiomas a matched case-control study 
856 4 0 |u https://doi.org/10.3389/fonc.2022.811729  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/article/10.3389/fonc.2022.811729  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220513 
993 |a Article 
994 |a 2022 
998 |g 1022852132  |a Sahm, Felix  |m 1022852132:Sahm, Felix  |d 910000  |d 912000  |d 50000  |e 910000PS1022852132  |e 912000PS1022852132  |e 50000PS1022852132  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 9 
999 |a KXP-PPN1801710732  |e 4133874293 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Matthias","family":"Millesi","display":"Millesi, Matthias","role":"aut"},{"given":"Alice Senta","family":"Ryba","display":"Ryba, Alice Senta","role":"aut"},{"family":"Hainfellner","role":"aut","display":"Hainfellner, Johannes A.","given":"Johannes A."},{"given":"Thomas","display":"Roetzer, Thomas","role":"aut","family":"Roetzer"},{"display":"Bergmeister-Berghoff, Anna Sophie","role":"aut","family":"Bergmeister-Berghoff","given":"Anna Sophie"},{"given":"Matthias","family":"Preusser","role":"aut","display":"Preusser, Matthias"},{"given":"Gerwin","display":"Heller, Gerwin","role":"aut","family":"Heller"},{"given":"Erwin","family":"Tomasich","role":"aut","display":"Tomasich, Erwin"},{"role":"aut","display":"Sahm, Felix","family":"Sahm","given":"Felix"},{"display":"Roessler, Karl","role":"aut","family":"Roessler","given":"Karl"},{"family":"Wolfsberger","display":"Wolfsberger, Stefan","role":"aut","given":"Stefan"}],"id":{"doi":["10.3389/fonc.2022.811729"],"eki":["1801710732"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"09 March 2022"}],"title":[{"title":"DNA methylation associates with clinical courses of atypical meningiomas","title_sort":"DNA methylation associates with clinical courses of atypical meningiomas","subtitle":"a matched case-control study"}],"name":{"displayForm":["Matthias Millesi, Alice Senta Ryba, Johannes A. Hainfellner, Thomas Roetzer, Anna Sophie Berghoff, Matthias Preusser, Gerwin Heller, Erwin Tomasich, Felix Sahm, Karl Roessler and Stefan Wolfsberger"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"10 S."}],"recId":"1801710732","relHost":[{"disp":"DNA methylation associates with clinical courses of atypical meningiomas a matched case-control studyFrontiers in oncology","title":[{"title":"Frontiers in oncology","title_sort":"Frontiers in oncology"}],"id":{"issn":["2234-943X"],"eki":["684965518"],"zdb":["2649216-7"]},"part":{"text":"12(2022), Artikel-ID 811729, Seite 1-10","year":"2022","volume":"12","pages":"1-10","extent":"10"},"origin":[{"publisherPlace":"Lausanne","dateIssuedKey":"2011","publisher":"Frontiers Media","dateIssuedDisp":"2011-"}],"pubHistory":["2011 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 07.11.13"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"684965518"}],"language":["eng"],"note":["Gesehen am 13.05.2022"]} 
SRT |a MILLESIMATDNAMETHYLA0920